Innocan Pharma (INNPF) Ending Cash Balance (2023 - 2025)
Innocan Pharma (INNPF) recorded Ending Cash Balance of $6.69 million in the quarter ended Dec 31, 2025, up 33.5% from $5.01 million a year earlier but down 8.0% from the prior quarter.
Powered by 
Analysis
Innocan Pharma (INNPF) Ending Cash Balance (2023 - 2025) Analysis & Trends
Starting with the quarter ended Dec 31, 2023, Innocan Pharma's Ending Cash Balance history includes 9 quarters.
- Across earlier years, Ending Cash Balance came in at $5.01 million in the year ended Dec 31, 2024 (+28.9%) and $3.89 million in the year ended Dec 31, 2023.
- Quarterly Ending Cash Balance has ranged from $3.89 million in the quarter ended Dec 31, 2023 to $7.27 million in the quarter ended Sep 30, 2025 over the past five years.
- On a year-over-year basis, Ending Cash Balance has increased for five consecutive quarters, with growth averaging 36.9% over the last five quarters.
- Per Business Quant, the preceding three quarters came in at $7.27 million (quarter ended Sep 30, 2025), $7.26 million (quarter ended Jun 30, 2025) and $6.37 million (quarter ended Mar 31, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 1.88 Bn |
| 10 | Innocan Pharma | 5.78 Mn | 1.73 Mn | 4.43 Mn | 6.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 6.69 Mn |
| Sep 30, 2025 | 7.27 Mn |
| Jun 30, 2025 | 7.26 Mn |
| Mar 31, 2025 | 6.37 Mn |
| Dec 31, 2024 | 5.01 Mn |
| Sep 30, 2024 | 5.06 Mn |
| Jun 30, 2024 | 5.19 Mn |
| Mar 31, 2024 | 4.60 Mn |
| Dec 31, 2023 | 3.89 Mn |
API Access
Innocan Pharma Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=INNPF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "INNPF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=INNPF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();